Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.20 +0.36 (+1.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Long-Term Debt Issuances (2020 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) recorded Long-Term Debt Issuances of $134.67 million in Q1 2026.

Analysis

Amneal Pharmaceuticals (AMRX) Long-Term Debt Issuances (2020 - 2026) Analysis & Trends

For FY2025, Amneal Pharmaceuticals reported Long-Term Debt Issuances of $2.69 billion.

  • Annual Long-Term Debt Issuances has a five-year compound annual growth rate of 71.8% (FY2020 to FY2025).
  • Across earlier years, Long-Term Debt Issuances came in at $217.73 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Amneal Pharmaceuticals 6.46 Bn 5.65 Bn 334.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 134.67 Mn
Sep 30, 2025 2.69 Bn
Mar 31, 2020 180.00 Mn
API Access

Amneal Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AMRX&period=max&api_key=YOUR_API_KEY